Each cancer consists of a diverse mix of cells. Each person’s immune system generates an individualized response against each specific cancer cell type. This results in extreme variabilities of interactions between people’s immune systems and their cancers. Delivering a cancer vaccine that stimulates the immune system to kill cancer cells (and only cancer cells) requires a broad and deep understanding of immunology.
In order to create such vaccines, we have created our proprietary databases by building a comprehensive taxonomy of immunological information linking genetics to cancer cell characteristics and proprietary algorithms to analyze billions of genes and compute patients’ immune responses against their specific types of cancer. We continually use the latest published scientific knowledge and proprietary learnings to update our databases and further refine our algorithms. Our ongoing quality control ensures data integrity and reliability.